drugset
drugset / Trial / NCT00705042

Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects

NCT00705042 ↗

Phase 1 Completed 60 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the Pharmacokinetics (PK) and safety and tolerability of etanercept, 25 and 50 mg, administered as a single dose to healthy male Chinese subjects.

Timeline

Start
2008-07
Primary completion
2008-09
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 25 mg Subcutaneous
Subject Etanercept Protein / enzyme biologic 50 mg Subcutaneous

Indications

No indication recorded.